taurolithocholic acid has been researched along with 2,5-di-tert-butylhydroquinone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caldwell, AM; Kolodziej, MP; Zammit, VA | 1 |
1 other study(ies) available for taurolithocholic acid and 2,5-di-tert-butylhydroquinone
| Article | Year |
|---|---|
Rapid decrease in the expression of 3-hydroxy-3-methylglutaryl-CoA reductase protein owing to inhibition of its rate of synthesis after Ca2+ mobilization in rat hepatocytes. Inability of taurolithocholate to mimic the effect.
Topics: Animals; Calcimycin; Calcium; Dose-Response Relationship, Drug; Female; Glucagon; Hydroquinones; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kinetics; Liver; Phenylephrine; Rats; Rats, Inbred Strains; Taurolithocholic Acid; Vasopressins | 1991 |